Why GLP-1 Drugs Work Better for Some People Than Others
A contrarian look at why GLP-1 drugs work differently, what the new genetics paper actually shows, and what patients should do with that information.
Foundayo: What Lilly’s New Weight Loss Pill Really Means
Foundayo is Lilly’s new oral GLP-1 pill for weight loss. Here is what it does, how it compares, side effects, and why convenience is not the whole story.
Retatrutide Phase 3 Diabetes Results: What They Actually Show
Retatrutide’s phase 3 diabetes data look strong on A1C and weight loss. Here is what the trial showed, what most coverage misses, and what patients should do now.